Stocks making big moves yesterday: Cogent, AdaptHealth, BWX, IQVIA, and Palantir Technologies

via StockStory
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

CCOI Cover Image

Check out the companies making headlines yesterday:

Cogent (NASDAQ:CCOI): Internet service provider Cogent Communications (NASDAQ:CCOI) rose by 7.2% on Tuesday after JPMorgan upgraded the stock to Overweight from Neutral, viewing the previous day's sharp sell-off as an attractive entry point. See our full article here.

Is now the time to buy Cogent? Access our full analysis report here, it's free.

AdaptHealth (NASDAQ:AHCO): Healthcare services provider AdaptHealth Corp. (NASDAQ:AHCO) fell by 8.5% on Tuesday after the company reported disappointing first-quarter 2026 results, where a significant earnings miss and worsening profitability overshadowed a revenue beat. See our full article here.

Is now the time to buy AdaptHealth? Access our full analysis report here, it's free.

BWX (NYSE:BWXT): Aerospace and defense company BWX (NYSE:BWXT) fell by 4.4% on Tuesday after its first-quarter earnings report, which beat expectations and included a guidance raise, failed to impress investors in a classic 'buy the rumor, sell the news' scenario. See our full article here.

Is now the time to buy BWX? Access our full analysis report here, it's free.

IQVIA (NYSE:IQV): Clinical research company IQVIA (NYSE: IQV) rose by 8.4% on Tuesday after it reported strong first-quarter 2026 financial results that surpassed Wall Street expectations and raised its full-year earnings forecast. See our full article here.

Is now the time to buy IQVIA? Access our full analysis report here, it's free.

Palantir Technologies (NASDAQ:PLTR): Data analytics company Palantir Technologies (NASDAQ:PLTR) fell by 6.6% on Tuesday after it reported first-quarter results that failed to impress markets despite beating analyst expectations and raising its full-year revenue forecast. See our full article here.

Is now the time to buy Palantir Technologies? Access our full analysis report here, it's free.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article